7,000 Steps Per Day Tied to Clinically Meaningful Benefits in Health Outcomes
TUESDAY, July 29, 2025 -- Seven thousand steps per day is associated with clinically meaningful improvements in health outcomes, according to a study published online July 23 in The Lancet Public Health.
Ding Ding, Ph.D., from the University of Sydney, and colleagues conducted a systematic literature review to evaluate the prospective, dose-response relationship between daily steps and health outcomes, including all-cause mortality.
Based on 57 studies (35 cohorts), the researchers found that for all-cause mortality, cardiovascular disease incidence, dementia, and falls, there was an inverse nonlinear dose-response association, with inflection points at around 5,000 to 7,000 steps per day. There was an inverse, linear association for cardiovascular disease mortality, cancer incidence, cancer mortality, type 2 diabetes incidence, and depressive symptoms. Based on 31 studies (24 cohorts) in the meta-analyses, compared with 2,000 steps per day, 7,000 steps per day were associated with a lower risk for all-cause mortality (hazard ratio [HR], 0.53; I² = 36.3 percent; 14 studies), cardiovascular disease incidence (HR, 0.75; I² = 38.3 percent; six studies), cardiovascular disease mortality (HR, 0.53; I² = 78.2 percent; three studies), cancer mortality (HR, 0.63; I² = 64.5 percent; three studies), type 2 diabetes (HR, 0.86; I² = 48.5 percent; four studies), dementia (HR, 0.62; I² = 0 percent; two studies), depressive symptoms (HR, 0.78; I² = 36.2 percent; three studies), and falls risk (HR, 0.72; I² = 47.5 percent; four studies). With the exception of cardiovascular disease mortality (low), cancer incidence (low), physical function (low), and falls (very low), the evidence certainty was moderate for all outcomes.
"Although 10,000 steps per day can still be a viable target for those who are more active, 7,000 steps per day is associated with clinically meaningful improvements in health outcomes and might be a more realistic and achievable target for some," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.